TATAA Biocenter Achieves GLP Accreditation for qPCR and dPCR
GOTHENBURG, Sweden, April 16, 2024 /PRNewswire/ -- TATAA Biocenter announced today that it has been awarded Good Laboratory Practice (GLP) accreditation. The accreditation represents a crucial step in the company's strategic progression into a market leading molecular analysis contract research organization (CRO) expediting biopharmaceutical innovations in advanced therapies and precision medicine.
- This important milestone for TATAA Biocenter provides customers access to safety testing, accelerating the transition of promising therapies from laboratory research and preclinical testing to clinical applications.
- GOTHENBURG, Sweden, April 16, 2024 /PRNewswire/ -- TATAA Biocenter announced today that it has been awarded Good Laboratory Practice (GLP) accreditation.
- With the addition of GLP accreditation to its existing Good Clinical Laboratory (GCLP) compliant work and ISO/IEC 17025 accreditation, TATAA Biocenter is now positioned to support clients through all development stages and regulatory filings.
- "As one of few laboratories with GLP accreditation for qPCR and dPCR, we can now support the pharmaceutical industry in a comprehensive way and accelerate the process through even more robust analyses, allowing therapies to reach the patient faster, " said Mathias Hallin, CEO of TATAA Biocenter.